EMBOLISM AND FILTERS USED IN CARDIOPULMONARY BYPASSGLORY MINI MOL. A
FILTERS USED IN CARDIOPULMONARY BYPASS
EMBOLISM
DEFINITION: obstruction of an artery, by a clot of blood or an air bubble.
This emboli is categorized to
Biological emboli
Foreign emboli
Gaseous emboli
There are current technologies to decrease this embolic event delivered to patient
Membrane oxygenators
FILTER
Blood surface coating
Bubble traps
Emboli detection system
Blood Filters
Depth filters
Consist of packed fibers of Dacron wool or
polyurethane foam .
No defined pore size
These filters have large wetted surface
areas to filter the blood by absorption , they are effective in
trapping gross bubbles.
Screen filters
composed of a woven
mesh of polyester fibers
defined pore sizes
From 20 -40 μm
(all of the arterial line filters used are the screen type)
EMBOLISM AND FILTERS USED IN CARDIOPULMONARY BYPASSGLORY MINI MOL. A
FILTERS USED IN CARDIOPULMONARY BYPASS
EMBOLISM
DEFINITION: obstruction of an artery, by a clot of blood or an air bubble.
This emboli is categorized to
Biological emboli
Foreign emboli
Gaseous emboli
There are current technologies to decrease this embolic event delivered to patient
Membrane oxygenators
FILTER
Blood surface coating
Bubble traps
Emboli detection system
Blood Filters
Depth filters
Consist of packed fibers of Dacron wool or
polyurethane foam .
No defined pore size
These filters have large wetted surface
areas to filter the blood by absorption , they are effective in
trapping gross bubbles.
Screen filters
composed of a woven
mesh of polyester fibers
defined pore sizes
From 20 -40 μm
(all of the arterial line filters used are the screen type)
Pulmonary edema is often caused by congestive heart failure. When the heart is not able to pump efficiently, blood can back up into the veins that take blood through the lungs. As the pressure in these blood vessels increases, fluid is pushed into the air spaces (alveoli) in the lungs.
Respiratory failure Concepts with sample mcqs Medico Apps
Respiratory Failure: Concepts and Sample MCQs
(For NEET PG, USMLE, PLAB, FMGE /MCI Screening Entrance Exams)
For more such notes and quizzes visit www.medicoapps.org
Gas exchange between the alveoli and the pulmonary capillary blood occurs by diffusion, as will be discussed in the next chapter. Diffusion of oxygen and carbon dioxide occurs passively, according to their concentration differences across the alveolar-capillary barrier. These concentration differences must be maintained by ventilation of the alveoli and perfusion of the pulmonary capillaries.
Alveolar ventilation brings oxygen into the lung and removes carbon dioxide from it. Similarly, the mixed venous blood brings carbon dioxide into the lung and takes up alveolar oxygen. The alveolar Image not available. and Image not available. are thus determined by the relationship between alveolar ventilation and pulmonary capillary perfusion. Alterations in the ratio of ventilation to perfusion, called the Image not available., will result in changes in the alveolar Image not available. and Image not available., as well as in gas delivery to or removal from the lung.
Alveolar ventilation is normally about 4 to 6 L/min and pulmonary blood flow (which is equal to cardiac output) has a similar range, and so the Image not available. for the whole lung is in the range of 0.8 to 1.2. Image not available. However, ventilation and perfusion must be matched on the alveolar-capillary level, and the Image not available. for the whole lung is really of interest only as an approximation of the situation in all the alveolar-capillary units of the lung. For instance, suppose that all 5 L/min of the cardiac output went to the left lung and all 5 L/min of alveolar ventilation went to the right lung. The whole lung Image not available. would be 1.0, but there would be no gas exchange because there could be no gas diffusion between the ventilated alveoli and the perfused pulmonary capillaries.
Oxygen is delivered to the alveolus by alveolar ventilation, is removed from the alveolus as it diffuses into the pulmonary capillary blood, and is carried away by blood flow. Similarly, carbon dioxide is delivered to the alveolus in the mixed venous blood and diffuses into the alveolus in the pulmonary capillary. The carbon dioxide is removed from the alveolus by alveolar ventilation. As will be discussed in Chapter 6, at resting cardiac outputs the diffusion of both oxygen and carbon dioxide is normally limited by pulmonary perfusion. Thus, the alveolar partial pressures of both oxygen and carbon dioxide are determined by the Image not available. If the Image not available. in an alveolar-capillary unit increases, the delivery of oxygen relative to its removal will increase, as will the removal ...
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
3. The lungs receive blood from pulmonary arteries and the bronchial arteries, that supply blood to
nourish the lung tissues.
Most of the blood from the lungs returns to the heart through the pulmonary veins ( left heart
venting necessary).
The longer the pump run the more likely there will be pulmonary dysfunction.
4. Triggers of lung impairment during CPB
Due to,
the CPB circuit with the patients’ blood being exposed to a wide range of synthetic materials (
results in SIRS and the ischemia –reperfusion injury). This can lead to
Post-op bleeding
Infection
MODs – ALI or ARDS
Alveolar and endothelial damage- resulting in Pulmonary edema, accumulation of alveolar
protein, facilitation of inflammatory cell sequestration and brocho-alveolar lavage fluid (thickened
alveolar-endothelial barrier).
Metabolic acidosis
Neutrofilic infiltration in lung tissues.
5. Respiratory changes after cardiac
surgery
Deleterious effect on the muscle pump and chest wall, phrenic nerve damage
and/or diaphragm dysfunction ( cold CPG solution)
Normal respiratory function may interfere both surgery stress and the
presence of chest tube drains.
Alveolar edema due to LV distension or elevated pressures.
Capillary permeability ( leading to alveolar flooding) may due to either
transfusion reactions or allergic reactions to drugs.
6. Lung mechanics
The mechanical properties of respiratory system is
referred as :
Compliance –
Describes the stiffness of the lungs
Change in volume over the changes in pressure
Elastance/ elastic recoil –
The tendency of the lung to return to its resting
state
Resistance –
Airway resistance
7. Effects of CPB on Lung mechanics:
- Thoracotomy decreases the lung compliance.
- Forced expiratory volume (FEV1) is decreased immediately after CABG.
- Changes in flows and volumes both reduces inspiratory strength and reduced on
uncoordinated ribcage expansion.
- Increases in respiratory rate and a decrease in Tidal volume(TV).
- Decrease in respiratory efficiency and increasing the oxygen cost of breathing.
8. Respiratory sequelae of CPB
Reduced respiratory system compliance
Increased respiratory system resistance
Reduced lung volumes and gas flows rates
Impaired gas exchange
Atelectasis
Phrenic nerve damage/ dysfunction
Reduced pump function (muscle weakness)
Cardiogenic pulmonary edema
‘Pump lung’ or ARDS
9. Phrenic nerve damage:
-Frost-bitten phrenic nerve was originally described in 1963.
-Phrenic nerve damage / dysfunction secondary to trauma or extreme cold may result in
significant post-op loss of lung volume.
10. Surfactant :
Special alveolar epithelial cells secrete surfactant leads to fluid that coat inside
surface of alveoli lead to 2-10 times decrease surface tension in alveoli which prevents
alveolar collapse
Alveoli lead to decrease surfactant result in increase surface tension lead to lung
collapse (The lack of surfactant function therefore leads to atelectasis).
Surfactant changes occur only after significant microvascular damage.
11.
12. Gas exchange:
Alveolar to arterial oxygen gradient increases immediately after cardiac surgery
Decrease in paO2 appears to be due to :
-The mechanical changes
-Atelectasis
-Decrease in lung volume
-Increase in pulmonary ventilation
-Pleural effusion and/or pleural thickening and greater still if an
internal mammary artery graft has been placed.
13. CPB induced Hemodilution and post-op
lung function
Hemodilution during CPB results from,
- Non-Haemic prime for the bypass circuitry
- Crystalloid CPG infusion
- Fluid administration by anesthetists
14. Starling equation which relates,
capillary permeability
factors to hydrostatic and colloid osmotic pressure
An increase in capillary hydrostatic pressure or reduction in colloid osmotic pressure should promote
fluid transduction from the capillary.
Hemodilution alone results in fluid accumulation and reduced plasma oncotic pressure (may responsible
for gas exchange abnormalities after CPB).
Interstitial and alveolar edema will develop due to trans-capillary fluid transduction (rapid or
excessive).
The development of lung edema after CPB due to post- op ventricular dysfunction.
15. When a decrease in capillary pressure, the Starling Equation suggests that fluid will move from the interstitial
space into the vascular space. This, finally, is what leads to anemia. The plasma is "diluted" by fluid shifting from
the interstitium.
16.
17.
18. oncotic pressure -
The osmotic pressure created by colloids (mainly plasma proteins) which are normally retained within
the vascular system;
oncotic pressure nearly offsets the hydrostatic pressure which acts to drive fluid out of vessels into the
extravascular space;
the result is that small amounts of fluid cross the vascular barrier, which are then transported back to
the blood via the lymphatics;
a decrease in oncotic pressure can be a cause of non-inflammatory edema.
edema -
Any excessive accumulation of serous fluid or interstitial fluid (lymph) in tissue spaces or a body cavity;
significant edema will produce obvious swelling of the involved tissues;
19. Post perfusion lung syndrome
Postperfusion lung syndrome is similar to adult respiratory distress syndrome
in clinical features, diagnostic approaches and management strategies. the
etiologies and predisposing risk factors may differ between each other.
The ARDS that develops early after cardiopulmonary bypass (CPB) is known as
post-perfusion or post-pump syndrome, which remains a significant clinical
problem on those patients receiving heart operations under CPB.
Postperfusion lung syndrome is rare but refractory.
20. Both ALI and ARDS were characterized by an acute onset, bilateral pulmonary infiltrations on
chest X-ray and pulmonary wedge pressure <18 mmHg.
The only differential criterion for both disorders was arterial oxygen tension (PaO2)/fractional
inspired oxygen (FiO2) <300 mmHg in ALI, but PaO2/FiO2 <200 mmHg in ARDS.
ARDS was classified into 3 levels based on degree of hypoxemia:
mild (200 mmHg < PaO2/FiO2 <300 mmHg)
moderate (100 mmHg <PaO2/FiO2 <200 mmHg)
severe (PaO2/FiO2 <100 mmHg)
21. CPB may be of considerable pulmonary pathophysiological consequences in terms of
the alveolar-arterial oxygenation gradient [P(A-a)O2],
intrapulmonary shunt,
degree of pulmonary edema,
pulmonary compliance
pulmonary vascular resistance,
may eventually lead to pulmonary dysfunction.
The respiratory dysfunction can be a result of pulmonary
ischemia-reperfusion injury, interstitial edema and
impaired microcirculation induced by CPB with activated
cytokines, enhanced reactive oxygen species and reduced
endogenous nitric oxide production
23. Pathophysiology
Respiratory indicators
PaO2/FiO2 - termed as oxygenation index, shows a good correlation with intrapulmonary shunting,
and can better reflect anoxia even in the condition of oxygen therapy
PaO2 - is easily influenced by mechanical ventilation. As PaO2 decreases in all types of respiratory
failure, it cannot reflect the actual respiratory function and may therefore be less reliable, but
leading to a delayed diagnosis if taken for an early diagnosis of ARDS
Arterial/alveolar oxygen tension ratio [P(A/a)O2] - is an indicator of gas exchange (oxygen intake)
impairment. Increase of P(A-a)O2 mean deficiency of gas exchange and is likely to be more sensitive
than the decrease of PaO2
Respiratory index (RI) is the ratio of P(A-a)O2 to PaO2. The normal range of RI is 0.1-0.3, ARDS
patients with sustained RI elevation may eventually develop multiple organ failure
24. Lung compliance
Type II cells main function is to produce surfactant.
Surfactant plays an essential role in preventing the alveoli from collapsing.
type II cell impairment may inevitably result in pulmonary compliance reduction.
a marked reduction in lung compliance, the work of breathing and the physiologic dead space
increase.
Mechanical ventilation may reverse hypoxemia of ALI and prevent from developing into ARDS.
With increasing PEEP, PaO2/FiO2 increases and static lung compliance stabilizes.
25. Extravascular lung water
It is composed of intracellular, intra-alveolar and alveolar interstitial fluid.
Increase of extravascular lung water is a prominent feature of ARDS and the actual reason for
refractory hypoxemia.
Clinically, extravascular lung water index (EVLWI) is an indicator for the description of extravascular
lung water. The normal range of EVLWI is 3.0-7.0 mL/kg. An EVLWI >7.0 mL/kg suggests the
presence of pulmonary edema.
ARDS closely correlated with increase of EVLWI and pulmonary vascular permeability index.
26. Intrapulmonary shunting
A pulmonary shunt is a condition of ventilation-perfusion mismatch
with normal blood perfusion but insufficient ventilation of the lungs.
The intrapulmonary shunt is optimal in assessing the severity of
hypoxemia.
Intrapulmonary shunting has a close relation negative to PaO2/FiO2,
but positive to P(A-a)O2, and is also affected by pulmonary artery
wedge pressure and cardiac index
27. Acid-base imbalances
In the early stage of ARDS, respiratory alkalosis is the most common type of acid-base imbalance
followed by metabolic acidosis and combined respiratory alkalosis and metabolic alkalosis.
while using diuretics and glucocorticoids (for metabolic alkalosis), or in the presence of severe hypoxia,
renal dysfunction, or shock (for metabolic acidosis) and electrolyte imbalance (hypokalemia, normal or
high blood chloride, and normal or reduced blood sodium)
In its late stage, patients may develop respiratory acidosis, respiratory acidosis associated with
metabolic acidosis and even triple acid-base imbalance.
occur in the condition of reduced ventilation and carbon dioxide retention, often associated with
normal or high blood potassium and normal or reduced blood chloride and sodium
28. Mechanism of post-perfusion lung
syndrome
- Remains uncertain
- May probably be due to the inflammatory cascade induced by contact
between blood and CPB circuit
subsequent activations of leukocytes, platelets,
coagulation and fibrinolysis system and kallikrein-
bradykinin and complement system
- After crossclamp removal, joint actions of protease release by leukocytes
in the pulmonary vascular beds, production of oxygen free radicals and intestinal
endotoxin translocation lead to increased pulmonary microvascular permeability,
microthrombus formation in the pulmonary vessels and the quality and quantity
changes of pulmonary surfactant predispose to the development of postperfusion
lung syndrome
29. RISK FACTORS
Insufficient perfusion of visceral organs caused by low output syndrome and
prolonged hypotension might be responsible.
Preoperative cardiac function impairment,
bloodstream infection,
prolonged crossclamp and operation durations,
hypotension episodes
hypogammaglobulinemia
30. PREVENTION
Choices of CPB circuit
Apparatus
Innovative CPB techniques
Modified surgical maneuvers
Medicinal agents - corticosteroids and aprotinin
Hyperonocotic CPB-prime with hydroxyethyl starch
32. Ventilatory treatment
Mechanical ventilation - high-frequency oscillatory ventilation
Patients with ALI/ARDS, mechanical ventilation with a lower tidal volume (6 mL/kg) than is
traditionally used.
Adequate PEEP levels avoid alveolar collapse and maintain sufficient pulmonary volume at the end
of expiration.
Excessive PEEP increases the risk of pneumothorax and airway impairment, causing adverse
hemodynamic effects by increasing intra-thoracic pressure and reducing venous return
inadequately low PEEP level provokes cyclic alveolar collapse and re-opening, resulting in
atelectrauma.
34. Extracorporeal membrane oxygenation (ECMO)
ECMO is a therapeutic option for patients with severe ARDS. The indications for ECMO use in ARDS
patients are failed conventional therapy for 24-96 hours and the conformity of two of the three
required slow-entry criteria for ECMO including PaO2/FiO2 <150 mmHg at PEEP >5 cmH2O, semistatic
compliance <30 mL/cmH2O and right-left shunt >30%. Only in the patients with life-threatening
hypoxemia (PaO2<50 mmHg at FiO2 1.0 and PEEP>5 cmH2O for>2 hours (fast-entry criteria) is
immediate ECMO commenced[81]. Mols et al.[82] reported one-quarter of their 245 ARDS patients
received ECMO treatment. The survival rate was 55% in ECMO patients and 61% in non-ECMO
patients. However, the role of ECMO in the treatment of ARDS is controversial[83]. In neonates
treated with ECMO, a survival rate of 80% was achieved. In adult patients with ARDS, two
randomized controlled trials revealed the survival rates were 10% and 33%, respectively, in the
ECMO groups[84]. Meta-analysis of 9 studies on a total of 1,058 patients with 386 of them treated
with ECMO revealed ECMO increased the mortality of ARDS patients. Therefore, it seems that ECMO
is not beneficial in adult patients with ARDS as in neonates
Editor's Notes
PaO2/FiO2 is affected by methods of oxygen supply and oxygen concentration, and hence it is an indicator of impairments of the pulmonary vascular beds and alveoli, irrelevant to extrapulmonary organ failure.
Increase in capillary endothelial and/or alveolar epithelial permeability and pulmonary surfactant deficiency from type II cell impairment may inevitably result in pulmonary compliance reduction.
The inflammatory process and alveolar flooding lead to severe ventilation-perfusion mismatch and intrapulmonary shunt, which are manifested clinically as severe hypoxia with a decrease in the PaO2/FiO2 ratio.
However, airway injury and hypokinemia may occur under the treatment of a high positive end-expiratory pressure (PEEP) and positive pressure support. This may in turn worsen the systemic inflammatory reactions and lead to extrapulmonary organ dysfunction or failure[22].
However, a 20-cmH2O PEEP can be a turning point of PaO2/FiO2 and static lung compliance fall
Extravascular lung water positively correlated with lung injury severity and oxygenation but negatively correlated pulmonary compliance
Alveolar macrophages are prone to be activated, releasing many inflammatory mediators including TNF-α, interleukin (IL)-6 and IL-8 and superoxide dismutase, etc., and damaging vascular endothelium and alveolar epithelium, thus making the lungs being the first target organ of insult. TNF-α and IL-6 may cause direct lung injury effects by inducing early inflammatory reactions, releasing toxic products and increasing pulmonary permeability[42]. In the lung, TNF-α is generated by activated pulmonary macrophages and accumulates in the bronchoalveolar lavage fluid of ALI patients[43]. The pathogenesis of TNF-α with receptors in neutrophil activation and infiltration of lung injury remain unclear. However, it has been noted that neutrophil accumulation and lung leak were abrogated in mice lacking the p55 TNF-α receptor[44]. TNF-α also stimulates the adhesions of the endothelial cells and neutrophils, and impacts a toxic effect by release of proteases, oxygen free radicals and superoxide dismutase. Productions of ILs including ILs-1, -2, -6 and -8 would be increased by stimulations of mon-macrocytes strengthening the lung injury. Accordingly, an early appearance of TNF-α may herald the development of ARDS and the synthesis and secretion of ILs
Both direct and indirect lung injuries can be predisposing risk factors leading to ARDS. Surgical trauma and CPB are among indirect risk factors.
Choices of CPB circuit - use of miniaturized circuits of CPB and circuit with biocompatible surfaces ultrafiltration
Apparatus - leukocyte depletion filters and ultrafiltration
Innovative CPB techniques (partial restoration of pulmonary artery perfusion during CPB)
Modified surgical maneuvers (reducing the use of cardiotomy suction device and reducing the contact-time between free blood and pericardium
Medicinal agents - as preventive strategies for ALI during CPB, which were proved to be of satisfactory outcomes on improving the lung function
hyperonocotic CPB-prime with hydroxyethyl starch 10% (200:0.5) may improve cardiac function and reduce pulmonary water content in the early postoperative period
Prone positioning improves gas exchange and has long been used as an adjunct or salvage therapy for severe or refractory ARDS. A strategy employing higher PEEP along with low tidal volume ventilation should be considered for ARDS patients receiving mechanical ventilation. ARDS patients receiving higher PEEP had a strong trend toward improved survival. However, higher PEEP had a strong trend toward harm as higher PEEP can conceivably cause ventilator-induced lung injury by increasing plateau pressures, or cause pneumothorax or decreased cardiac output
Prostaglandins are endogenous derivatives of arachidonic acid with properties of vasodilation, platelet aggregation inhibition and anti-inflammation. Inhaled prostacyclins cause selective pulmonary vasodilation, thereby enhancing lung function by improving ventilation-perfusion mismatch and oxygenation and by reducing pulmonary vascular resistance
Glucocorticoids can reduce inflammation and fibrosis through inhibition of several cytokines including ILs-1, -3, -5, -6 and -8, TNF-α and granulocyte macrophage-colony stimulating factor.
High-mobility group box 1 (HMGB1) is a critical mediator in the pathogenesis of many inflammatory diseases. Penehyclidine hydrochloride inhibits the translocation of release of HMGB1 from the nucleus to the cytoplasm and the expression of HMGB1 messenger ribonucleic acid in a dose-dependent manner